State Street’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-812,455
| Closed | -$4.19M | – | 3867 |
|
|
2019
Q2 | $4.19M | Buy |
812,455
+16,296
| +2% | +$73.2K | ﹤0.01% | 2924 |
|
|
2019
Q1 | $2.87M | Buy |
796,159
+66,746
| +9% | +$289K | ﹤0.01% | 3013 |
|
|
2018
Q4 | $4.47M | Buy |
729,413
+30,854
| +4% | +$188K | ﹤0.01% | 2770 |
|
|
2018
Q3 | $4.08M | Buy |
698,559
+24,363
| +4% | +$122K | ﹤0.01% | 2957 |
|
|
2018
Q2 | $2.87M | Buy |
674,196
+9,793
| +1% | +$49.4K | ﹤0.01% | 3114 |
|
|
2018
Q1 | $2.93M | Buy |
664,403
+11,341
| +2% | +$50.6K | ﹤0.01% | 3020 |
|
|
2017
Q4 | $3.44M | Buy |
653,062
+55,158
| +9% | +$337K | ﹤0.01% | 2960 |
|
|
2017
Q3 | $3.67M | Buy |
597,904
+724
| +0.1% | +$4.58K | ﹤0.01% | 2941 |
|
|
2017
Q2 | $4.32M | Buy |
597,180
+55,480
| +10% | +$341K | ﹤0.01% | 2809 |
|
|
2017
Q1 | $2.87M | Sell |
541,700
-111,572
| -17% | -$753K | ﹤0.01% | 2954 |
|
|
2016
Q4 | $4.69M | Sell |
653,272
-23,311
| -3% | -$188K | ﹤0.01% | 2725 |
|
|
2016
Q3 | $6.33M | Buy |
676,583
+76,228
| +13% | +$633K | ﹤0.01% | 2429 |
|
|
2016
Q2 | $3.79M | Buy |
600,355
+82,168
| +16% | +$528K | ﹤0.01% | 2758 |
|
|
2016
Q1 | $2.87M | Buy |
518,187
+73,460
| +17% | +$276K | ﹤0.01% | 2841 |
|
|
2015
Q4 | $2.48M | Sell |
444,727
-646,826
| -59% | -$4.27M | ﹤0.01% | 2910 |
|
|
2015
Q3 | $9.24M | Buy |
1,091,553
+96,692
| +10% | +$1.64M | ﹤0.01% | 2222 |
|
|
2015
Q2 | $15M | Sell |
994,861
-25,359
| -2% | -$366K | ﹤0.01% | 2029 |
|
|
2015
Q1 | $16.3M | Buy |
1,020,220
+674,051
| +195% | +$12M | ﹤0.01% | 1956 |
|
|
2014
Q4 | $6.17M | Buy |
346,169
+41,516
| +14% | +$517K | ﹤0.01% | 2465 |
|
|
2014
Q3 | $3.06M | Buy |
304,653
+13,362
| +5% | +$162K | ﹤0.01% | 2802 |
|
|
2014
Q2 | $4.55M | Buy |
291,291
+166,633
| +134% | +$2.36M | ﹤0.01% | 2647 |
|
|
2014
Q1 | $2.31M | Buy |
124,658
+48,991
| +65% | +$982K | ﹤0.01% | 2996 |
|
|
2013
Q4 | $1.45M | Buy |
75,667
+31,307
| +71% | +$636K | ﹤0.01% | 3179 |
|
|
2013
Q3 | $726K | Buy |
+44,360
| New | +$466K | ﹤0.01% | 3301 |
|
Other funds holding PETX
State Street's PETX Position: Q3 2019 in Review
State Street sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 812,455 shares — an estimated $4.19M sold.
State Street first reported a position in PETX in Q3 2013 and held it in 24 quarters. The position peaked at $16.3M in Q1 2015. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- State Street reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- State Street sold 812,455 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $4.19M.
- State Street first reported a position in Aratana Therapeutics, Inc. in Q3 2013 and held it in 24 quarters.
- State Street's Aratana Therapeutics, Inc. position peaked at $16.3M in Q1 2015.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on State Street's 13F filing for Q3 2019, filed 14 Nov 2019.